These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11401995)

  • 41. Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection.
    Aline F; Bout D; Amigorena S; Roingeard P; Dimier-Poisson I
    Infect Immun; 2004 Jul; 72(7):4127-37. PubMed ID: 15213158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
    J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Inhibitory effect of dendritic cells pulsed with MAGE-3 peptide on transplanted murine gastric cancer in mice].
    Lü B; Liu BY; Zhang Y; Chen XH; Zhu ZG; Yin HR; Lin YZ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2120-3. PubMed ID: 16313822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD4+ T cell-independent maintenance and expansion of memory CD8+ T cells derived from in vitro dendritic cell activation.
    Shi M; Xiang J
    Int Immunol; 2006 Jun; 18(6):887-95. PubMed ID: 16621867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
    Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
    J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunization with dendritic cells retrovirally transduced with mycobacterial antigen 85A gene elicits the specific cellular immunity including cytotoxic T-lymphocyte activity specific to an epitope on antigen 85A.
    Nakano H; Nagata T; Suda T; Tanaka T; Aoshi T; Uchijima M; Kuwayama S; Kanamaru N; Chida K; Nakamura H; Okada M; Koide Y
    Vaccine; 2006 Mar; 24(12):2110-9. PubMed ID: 16352377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination.
    Kim SG; Park MY; Kim CH; Sohn HJ; Kim HS; Park JS; Kim HJ; Oh ST; Kim TG
    Vaccine; 2008 Nov; 26(50):6433-40. PubMed ID: 18812201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apoptosis induced by Pseudomonas aeruginosa in antigen presenting cells is diminished by genetic modification with CD40 ligand.
    Worgall S; Martushova K; Busch A; Lande L; Crystal RG
    Pediatr Res; 2002 Nov; 52(5):636-44. PubMed ID: 12409507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization.
    Lange KH; Hougen HP; Høiby N; Fomsgaard A; Rygaard J; Johansen HK
    APMIS; 1995 May; 103(5):367-74. PubMed ID: 7654361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccine strategies against Pseudomonas aeruginosa infection in the lung.
    Cripps AW; Dunkley ML; Clancy RL; Kyd J
    Behring Inst Mitt; 1997 Feb; (98):262-8. PubMed ID: 9382749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cross-strain protection against clinical and laboratory strains of Pseudomonas aeruginosa mediated by dendritic cells genetically modified to express CD40 ligand and pulsed with specific strains of Pseudomonas aeruginosa.
    Kikuchi T; Hackett NR; Crystal RG
    Hum Gene Ther; 2001 Jul; 12(10):1251-63. PubMed ID: 11440619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective characteristics of the antigen common to Pseudomonas and Vibrio and significance of bacterial endotoxins in protection against selected bacterial infections.
    Sourek J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):538-47. PubMed ID: 2413656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective effect of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to), on Pseudomonas aeruginosa infection in mice.
    Kawakita T; Yamada A; Mitsuyama M; Kumazawa Y; Nomoto K
    Immunopharmacol Immunotoxicol; 1987; 9(4):523-40. PubMed ID: 3437105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exposure of mice to live Pseudomonas aeruginosa generates protective cell-mediated immunity in the absence of an antibody response.
    Markham RB; Powderly WG
    J Immunol; 1988 Mar; 140(6):2039-45. PubMed ID: 3126239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines.
    Joó I; Stanislavsky ES; Zhvanetskaya MI; Mashilova GM; Gladus MA
    Acta Microbiol Acad Sci Hung; 1982; 29(4):267-75. PubMed ID: 6821018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection.
    Okada K; Kawaharajo K; Kasai T; Homma JY
    Jpn J Exp Med; 1980 Feb; 50(1):53-61. PubMed ID: 6770131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thermal injury-induced non-specific resistance to fatal Pseudomonas aeruginosa burn-infection in mice.
    Pinto M; Zehavi-Willner T
    Jpn J Exp Med; 1989 Oct; 59(5):189-96. PubMed ID: 2559218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae.
    Su H; Messer R; Whitmire W; Fischer E; Portis JC; Caldwell HD
    J Exp Med; 1998 Sep; 188(5):809-18. PubMed ID: 9730883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection.
    Li P; Wang X; Sun X; Guan Z; Sun W
    mSphere; 2021 Oct; 6(5):e0069921. PubMed ID: 34612675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.